Developing a data commons for cancer immune monitoring and analysis.
CLINICAL AND TRANSLATIONAL DATA COMMONS (CTDC) AND IMMUNE ONCOLOGY DATA HARMONIZATION/MAPPING (IODH/M)
This study is working to bring together and organize important cancer-related information, especially about how the immune system responds to cancer, so that researchers can easily access high-quality data to help develop better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11219255 on NIH RePORTER |
What this research studies
This project focuses on creating and maintaining a comprehensive data commons that integrates various cancer-related datasets, particularly those related to immune monitoring. It aims to standardize and harmonize data from multiple sources, including clinical trials and biological assays, to ensure high-quality data is available for researchers and the public. By automating workflows for data validation and curation, the project seeks to enhance the accessibility and usability of cancer immunology data. Patients may benefit from improved research outcomes and more effective treatments based on this harmonized data.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include patients involved in clinical trials for cancer immunotherapies.
Not a fit: Patients with cancers that are not part of the immuno-oncology focus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by providing researchers with high-quality, standardized data.
How similar studies have performed: Other research initiatives have successfully utilized data commons approaches to enhance cancer research, indicating a promising potential for this project.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.